Accessed 8 Aug 2023 Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA
rhamnosus GG emerged as the most consistently effective, reducing plasma TMAO in both contexts
You might experience longer-lasting headaches, deeper fatigue, and more pronounced nausea
The eagerly awaited ESSENCE trial (NEJM, April 2025) reports that once-weekly semaglutide 2.4 mg achieved statistically significant and clinically meaningful improvements in patients with biopsy-proven metabolic dysfunctionassociated steatohepatitis (MASH) and fibrosis stage 23
Keep everything in one system
It is more common is children than adults, and commonly appears on the face, elbows, knees, hands, or feet